METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) AND CARDIOMETABOLIC HEALTH EDUCATIONAL INITIATIVE WITH INTERNAL MEDICINE RESIDENTS

• Hoofdauteur: Jack Jnani, MD (Auteur)
• Formaat: Boek
• Gepubliceerd in: Elsevier, 2024-09-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Therapeutic Area: Metabolic Syndrome Background: Metabolic dysfunction-associated fatty liver disease (MAFLD) is one of the most common causes of cirrhosis in the United States, and cardiovascular disease is a leading cause of mortality in patients with MAFLD. The presentation is usually asymptomati...